single and twin elective cesarean section
Conditions
Interventions
Group A-1:Infusion of norepinephrine at a constant rate of 0.02ug/kg/min
Group A-2:Infusion of norepinephrine at a constant rate of 0.03ug/kg/min
Group A-3:Infusion of norepinephrine at a constant rate of 0.04ug/kg/min
Group A-4:Infusion of norepinephrine at a constant rate of 0.05ug/kg/min
Group A-5:Infusion of norepinephrine at a constant rate of 0.06ug/kg/min
Group B-1: Infusion of norepinephrine at a constant rate of 0.02ug/kg/min
Group B-2: Infusion of norepinephrine at a constant rate of 0.03ug/kg/min
Group B-3: Infusion of norepinephrine at a constant rate of 0.04ug/kg/min
Group B-4: Infusion of norepinephrine at a constant rate of 0.05ug/kg/min
Group B-5:Infusion of norepinephrine at a constant rate of 0.06ug/kg/min
Sponsors
Womens' Hospital, School of Medicine, Zhejiang University
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria of group A were: (1) ASA grade 2; (2) parturients aged 18 to 40 years; (3) BMI= 37 weeks), elective Single-birth cesarean section. Inclusion criteria for group B were: (1) ASA grade 2; (2) puerpera aged 18 to 40 years; (3) BMI = 34 weeks) elective twin cesarean section.
Exclusion criteria
Exclusion criteria: Exclusion criteria for group A were: (1) contraindication of intraspinal anesthesia; (2) allergy to amide local anesthetics; (3) basal systolic blood pressure <= 100 mmHg; (4) pregnancy induced hypertension or preeclampsia; (5) gestational diabetes mellitus; (6) asthma and cardiac diseases requiring treatment; (7) refusal to sign informed consent; (8) its Other conditions: such as ruptured membranes, active labor process, twin and multiple pregnancy cesarean section, intrauterine growth restriction, placenta previa, fetal congenital abnormalities, etc. Exclusion criteria for group B were: (1) intraspinal anesthesia contraindication; (2) allergic to amide local anesthetics; (3) basal systolic blood pressure <= 100 mmHg; (4) severe gestational hypertension or preeclampsia; (5) uncontrolled severe gestational diabetes mellitus; (6) asthma and heart disease requiring treatment; (7) refusal to sign. Informed consent; (8) Other conditions: ruptured membranes, active labor, single, triplets and above cesarean section, intrauterine growth restriction, placenta previa, fetal congenital abnormalities, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of hypotension;Number of interventions;Dosage of vasoactive drugs;Maternal outcomes (Nausea and Vomiting; Bradycardia; Tachycardia; Hypertension; Dizzy; Dyspnea);Maternal outcomes (Nausea and Vomiting; Bradycardia; Tachycardia; Hypertension; Dizzy; Dyspnea); | — |
Countries
China
Contacts
Public ContactXiaowei Qian
Womens' Hospital, School of Medicine, Zhejiang University
Outcome results
None listed